Botulinum Toxin Type A Injection for Spastic Equinovarus Foot in Children with Spastic Cerebral Palsy: Effects on Gait and Foot Pressure Distribution
- PMID: 26847306
- PMCID: PMC4740546
- DOI: 10.3349/ymj.2016.57.2.496
Botulinum Toxin Type A Injection for Spastic Equinovarus Foot in Children with Spastic Cerebral Palsy: Effects on Gait and Foot Pressure Distribution
Abstract
Purpose: To investigate the effect of intramuscular Botulinum toxin type A (BoNT-A) injection on gait and dynamic foot pressure distribution in children with spastic cerebral palsy (CP) with dynamic equinovarus foot.
Materials and methods: Twenty-five legs of 25 children with CP were investigated in this study. BoNT-A was injected into the gastrocnemius (GCM) and tibialis posterior (TP) muscles under the guidance of ultrasonography. The effects of the toxin were clinically assessed using the modified Ashworth scale (MAS) and modified Tardieu scale (MTS), and a computerized gait analysis and dynamic foot pressure measurements using the F-scan system were also performed before injection and at 1 and 4 months after injection.
Results: Spasticity of the ankle plantar-flexor in both the MAS and MTS was significantly reduced at both 1 and 4 months after injection. On dynamic foot pressure measurements, the center of pressure index and coronal index, which represent the asymmetrical weight-bearing of the medial and lateral columns of the foot, significantly improved at both 1 and 4 months after injection. The dynamic foot pressure index, total contact area, contact length and hind foot contact width all increased at 1 month after injection, suggesting better heel contact. Ankle kinematic data were significantly improved at both 1 and 4 months after injection, and ankle power generation was significantly increased at 4 months after injection compared to baseline data.
Conclusion: Using a computerized gait analysis and foot scan, this study revealed significant benefits of BoNT-A injection into the GCM and TP muscles for dynamic equinovarus foot in children with spastic CP.
Keywords: Botulinum toxin type A; cerebral palsy; equinovarus deformity.
Conflict of interest statement
The authors have no financial conflicts of interest.
Figures
Similar articles
-
Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.J Neuroeng Rehabil. 2016 Mar 12;13:25. doi: 10.1186/s12984-016-0135-8. J Neuroeng Rehabil. 2016. PMID: 26969526 Free PMC article. Clinical Trial.
-
[Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study].Rev Chir Orthop Reparatrice Appar Mot. 1999 May;85(2):156-63. Rev Chir Orthop Reparatrice Appar Mot. 1999. PMID: 10392416 Clinical Trial. French.
-
Effects of botulinum toxin-A on gait velocity, step length, and base of support of patients with dynamic equinovarus foot.Am J Phys Med Rehabil. 2006 Jul;85(7):600-6. doi: 10.1097/01.phm.0000223216.50068.bc. Am J Phys Med Rehabil. 2006. PMID: 16788391
-
Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.J Neural Transm (Vienna). 2009 Mar;116(3):319-31. doi: 10.1007/s00702-008-0175-8. Epub 2009 Jan 14. J Neural Transm (Vienna). 2009. PMID: 19142573 Review.
-
Botulinum Toxin in the Management of Children with Cerebral Palsy.Paediatr Drugs. 2019 Aug;21(4):261-281. doi: 10.1007/s40272-019-00344-8. Paediatr Drugs. 2019. PMID: 31257556 Free PMC article. Review.
Cited by
-
Abnormal Foot Position and Standing and Walking Ability in Rett Syndrome: an Exploratory Study.J Dev Phys Disabil. 2018;30(2):281-295. doi: 10.1007/s10882-017-9585-6. Epub 2018 Jan 2. J Dev Phys Disabil. 2018. PMID: 29563764 Free PMC article.
-
Botulinum Toxin Intervention in Cerebral Palsy-Induced Spasticity Management: Projected and Contradictory Effects on Skeletal Muscles.Toxins (Basel). 2022 Nov 8;14(11):772. doi: 10.3390/toxins14110772. Toxins (Basel). 2022. PMID: 36356022 Free PMC article. Review.
-
Assessing Gross Motor and Gait Function Using Hip-Knee Cyclograms in Ambulatory Children with Spastic Cerebral Palsy.Sensors (Basel). 2025 Jul 18;25(14):4485. doi: 10.3390/s25144485. Sensors (Basel). 2025. PMID: 40732612 Free PMC article.
-
Spatiotemporal Characteristics of Freezing of Gait in Patients After Hypoxic-Ischemic Brain Injury: A Pilot Study.Medicine (Baltimore). 2016 May;95(19):e3666. doi: 10.1097/MD.0000000000003666. Medicine (Baltimore). 2016. PMID: 27175696 Free PMC article.
-
Determinants of Hip and Femoral Deformities in Children With Spastic Cerebral Palsy.Ann Rehabil Med. 2018 Apr;42(2):277-285. doi: 10.5535/arm.2018.42.2.277. Epub 2018 Apr 30. Ann Rehabil Med. 2018. PMID: 29765881 Free PMC article.
References
-
- Cardoso ES, Rodrigues BM, Barroso M, Menezes CJ, Lucena RS, Nora DB, et al. Botulinum toxin type A for the treatment of the spastic equinus foot in cerebral palsy. Pediatr Neurol. 2006;34:106–109. - PubMed
-
- Simpson DM, Gracies JM, Graham HK, Miyasaki JM, Naumann M, Russman B, et al. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008;70:1691–1698. - PubMed
-
- Ghotbi N, Ansari NN, Naghdi S, Hasson S, Jamshidpour B, Amiri S. Inter-rater reliability of the Modified Modified Ashworth Scale in assessing lower limb muscle spasticity. Brain Inj. 2009;23:815–819. - PubMed
-
- Reiter F, Danni M, Lagalla G, Ceravolo G, Provinciali L. Low-dose botulinum toxin with ankle taping for the treatment of spastic equinovarus foot after stroke. Arch Phys Med Rehabil. 1998;79:532–535. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous